Nathan Stehouwer, MD
-
Specialty: Internal Medicine, Pediatrics
View Expertise -
Primary Location: 11100 Euclid Ave (0 mi.)
Other Locations - Languages Spoken: English
Office Locations
CMC Medical Center (0 mi.)
11100 Euclid Ave
Bolwell Ste 3400
Cleveland, OH 44106
216-844-3400
Biography: Nathan Stehouwer, MD
Expertise
Titles
- Director, Med/Ped Consult Service, UH Cleveland Medical Center
- Program Director, Medicine/Pediatrics, UH Cleveland Medical Center
- Assistant Professor of Pediatrics, CWRU School of Medicine
- Assistant Professor of Medicine, CWRU School of Medicine
Certifications & Memberships
- Pediatrics - American Board of Pediatrics
- Internal Medicine - American Board of Internal Medicine
Education
Residency | Medicine/Pediatrics-Chief Resident
Medicine/Pediatrics-Chief Resident - Uh Case Medical Center (2015 - 2016)
Residency | Internal Medicine/Pediatrics
Internal Medicine/Pediatrics - Uh Case Medical Center (2011 - 2015)
Medical Education
Case Western Reserve University School Of Medicine (2011)
Undergraduate
Calvin College (2007)
About
Dr. Stehouwer received his undergraduate degree in philosophy from Calvin College and his MD from Case Western Reserve University School of Medicine. He completed his Med-Peds residency at University Hospitals Rainbow Babies & Children's Hospital, where he served an additional year as Med-Peds chief resident.
Dr. Stehouwer is the Medical Director of the Med-Peds consult service for young adults with childhood illnesses admitted to the pediatric or adult hospitals, including patients with developmental disorders, sickle cell disease, and congenital heart disease. His research interests include transitions of care, care of young adults with developmental disorders, and diagnostic reasoning. He also works in the Quality Institute at University Hospitals.
Dr. Stehouwer enjoys playing with his two young sons, cycling, cooking, and watching Cleveland sports.
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Nathan Stehouwer did not disclose any Outside Relationships with Industry.